1. Ceratonia siliqua L. pod Effects on Viability Gene Expression of Endometrial Mesenchymal Stromal/Stem Cells Isolated from Women with Endometriosis-Associated Infertility.
- Author
-
Khodabandeh, Zahra, Jahromi, Bahia Namavar, Hashemi, Atefe, Hessami, Kamran, Jamhiri, Iman, Zare, Shahrokh, Badr, Parmis, Iraji, Aida, Poordast, Tahere, Baghban, Neda, Khoradmehr, Arezoo, Maratovich Mussin, Nadiar, Askerovich Kaliyev, Asset, Maratovich Iztleuov, Yerbolat, Shirazi, Reza, Mahdipour, Mahdi, Bakhshalizadeh, Shabnam, Rahmanifar, Farhad, Jafari, Nazanin, and Tanideh, Nader
- Subjects
FRUIT ,FERTILITY drugs ,DNA methyltransferases ,COMPUTER-assisted molecular modeling ,IN vitro studies ,ENDOMETRIUM ,INFERTILITY ,MESENCHYMAL stem cells ,APOPTOSIS ,REVERSE transcriptase polymerase chain reaction ,TREATMENT effectiveness ,ENDOMETRIOSIS ,PLANT extracts ,GENE expression ,MESSENGER RNA ,EXPERIMENTAL design ,RNA probes ,GAS chromatography ,MEDICINAL plants ,MATRIX metalloproteinases ,OXIDOREDUCTASES ,WESTERN immunoblotting ,GENE expression profiling ,MASS spectrometry ,CELL survival ,ORGANIC compounds ,INFLAMMATION ,HISTONE deacetylase ,PHARMACODYNAMICS ,DISEASE complications - Abstract
Background: This study aims to investigate the effects of carob (Ceratonia siliqua L.) pod extract (CPE) on the viability of human endometrial mesenchymal stromal/stem cells (EnMSCs) and its impact on mRNA and protein expressions of DNA methyltransferases (DNMT1, DNMT3A, and DNMT3B), histone deacetylase 1 (HDAC1), matrix metalloproteinase-2 (MMP2), and cyclooxygenase-2 (COX-2) in endometriotic patients. Materials and Methods: In this experimental study, EnMSCs were derived from endometrium of patients with ovarian endometrioma (OMA-EnMSCs group) and deep infiltrative endometriosis (DIE) samples of 10 endometriosis-associated infertility (EAI) women (E-EnMSCs group) and compared to EnMSCs derived from the endometrium of an endometriosis-free, normal woman as the control group (C-EnMSCs). The metabolic activity of the control and case groups were evaluated by treating them with different concentrations of CPE. Cell viability was analysed by MTT. Real-time reverse transcription-polymerase chain reaction (RT-PCR) and Western blot were used to evaluate the expression of specific genes at the mRNA and protein levels, respectively. Results: Treatment with 0.8 and 2 μg/mL of CPE downregulated COX-2 and HDAC1 in the E-EnMSC group compared to the C-EnMSCs group. Treatment with 0.8 μg/mL of CPE also decreased MMP2 and DNMT3B gene expressions. The COX-2 and DNMT3A genes were significantly upregulated after treatment with 2 μg/mL of CPE. Expressions of the COX-2, HDAC1, DNMT1, DNMT3A, and DNMT3B peptides decreased in the all three groups after treatment with 0.8 and 2 μg/mL of CPE. Gas chromatography-mass spectroscopy (GC-MS) analysis of CPE identified 14 bioactive compounds. Molecular docking showed the best position of each bioactive compound on the different target proteins that are involved in the process of apoptosis in EnMSCs. Conclusion: In vitro and in silico analyses of CPE bioactive compounds show that they may downregulate the cell inflammatory pathway involved in the pathophysiology of endometriosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF